Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| AIM Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on January 23, 2023, AIM opened at $0.66, traded as high as $0.70 and as low as $0.63, and closed at $0.66. Trading volume was a total of 288.00K shares. On January 24, 2023, AIM opened at $0.66, traded as high as $0.67 and as low as $0.64, and closed at $0.65. Trading volume was a total of 118.60K shares. On January 25, 2023, AIM opened at $0.65, traded as high as $0.67 and as low as $0.63, and closed at $0.65. Trading volume was a total of 81.00K shares. On January 26, 2023, AIM opened at $0.64, traded as high as $0.64 and as low as $0.57, and closed at $0.59. Trading volume was a total of 195.40K shares. On January 27, 2023, AIM opened at $0.60, traded as high as $0.60 and as low as $0.55, and closed at $0.56. Trading volume was a total of 259.70K shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 01/30/2013 | |
| End date: | 01/27/2023 | |
| Start price/share: | $0.30 | |
| End price/share: | $0.56 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 86.67% | |
| Average Annual Total Return: | 6.44% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $18,662.70 | |
| Years: | 10.00 | |
 | |||||
| AIM Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/23/2023 | $0.66 | $0.70 | $0.63 | $0.66 | 288.00K |
| 01/24/2023 | $0.66 | $0.67 | $0.64 | $0.65 | 118.60K |
| 01/25/2023 | $0.65 | $0.67 | $0.63 | $0.65 | 81.00K |
| 01/26/2023 | $0.64 | $0.64 | $0.57 | $0.59 | 195.40K |
| 01/27/2023 | $0.60 | $0.60 | $0.55 | $0.56 | 259.70K |
|
| About AIM ImmunoTech |
| AIM ImmunoTech is an immuno-pharma company that is focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders. Co.'s primary pharmaceutical product platform consists of Ampligen® and Alferon N Injection®. Ampligen® is approved for sale in Argentina for severe Chronic Fatigue Syndrome (CFS) and is an experimental drug in the U.S. undergoing clinical development for the treatment of certain cancers and myalgic encephalomyelitis/CFS. Alferon N Injection® is a natural alpha interferon for the intralesionaltreatment of refractory or recurring external genital warts in patients 18 years of age or older. |
| AIM Historical Closing Prices | |
| Date | Close |
| 01/23/2023 | $0.66 |
| 01/24/2023 | $0.65 |
| 01/25/2023 | $0.65 |
| 01/26/2023 | $0.59 |
| 01/27/2023 | $0.56 |
| Healthcare Historical Prices |
| AIM is categorized under the Healthcare sector; below are some other companies in the same sector:
AIMT Historical Stock Prices
|
Free AIM Email Alerts:
